What this instrument does
The National Health (Listed drugs on F1 or F2) Amendment Determination (No. 7) 2026 is a technical update to the list of medicines classified as F1 or F2 under the national Pharmaceutical Benefits Scheme (PBS) pricing rules. It was made under the National Health Act 1953.
The source text does not specify which drugs were added, removed, or moved between the F1 and F2 formularies. It states only that amendments were made to the 2021 determination.
Timing
The determination applied from 31 July 2026. It has since been repealed as of 12 October 2026, meaning it has already run its course and been superseded.
Administration
This type of instrument is administered by the Department of Health, Disability and Ageing. It mainly affects pharmacies and health providers who rely on current PBS listings for pricing and dispensing.
Key actions
- Pharmacy or health businesses affected by PBS drug listings can check the Federal Register of Legislation page at https://www.legislation.gov.au/F2026L01018 to view the full legislation text and explanatory statement for exact schedule details
- Confirmation with PBS pricing or dispensing software providers that current F1/F2 listings reflect the latest determination is relevant, since this instrument has already been repealed and superseded
- The 'Set up an alert' or 'Save this title to My Account' features on the Federal Register of Legislation page can be used to track further amendments to this determination
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.